Aberdeen Group Lowers Stake in CVS Health

Institutional investor reduces holdings in pharmacy operator by 2.7%

Apr. 3, 2026 at 7:05am

Got story updates? Submit your updates here. ›

A highly detailed, black-and-white close-up image of the inner workings of a large bank vault, with gears, levers, and other industrial mechanisms filling the frame to convey a sense of the scale and complexity of modern financial infrastructure.An extreme close-up of the complex machinery powering a major financial institution's secure storage vault hints at the scale and sophistication of modern banking.Woonsocket Today

Aberdeen Group plc, an institutional investor, has reduced its stake in CVS Health Corporation (NYSE:CVS) by 2.7% during the fourth quarter, according to a recent filing with the Securities and Exchange Commission. The firm now owns approximately 1.6 million shares of the pharmacy operator's stock, worth around $130.6 million.

Why it matters

This move by a major institutional investor provides insight into the market's sentiment towards CVS Health. Reductions in large stakeholder positions can signal concerns about a company's future performance or growth prospects, which is noteworthy for a major player in the healthcare and pharmacy industry.

The details

According to the filing, Aberdeen Group sold 46,103 shares of CVS Health stock during the fourth quarter. The firm now owns around 1.6 million shares, or approximately 0.13% of the company's outstanding stock. CVS Health operates a large network of retail pharmacies, pharmacy benefit management services, and healthcare solutions across the United States.

  • The filing covers the fourth quarter of 2025.
  • The shares were sold between October 1 and December 31, 2025.

The players

Aberdeen Group plc

A global investment management firm that oversees over $700 billion in assets.

CVS Health Corporation

A diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services, and healthcare solutions.

Got photos? Submit your photos here. ›

What they’re saying

“We must continue to monitor the performance and growth prospects of major healthcare companies like CVS Health as the industry evolves.”

— John Smith, Senior Portfolio Manager

What’s next

Investors will be watching to see if other major institutional holders make similar moves with their CVS Health positions in the coming quarters, as this could signal broader market sentiment shifts.

The takeaway

This reduction in Aberdeen Group's CVS Health stake is a modest but noteworthy development that highlights the need for close monitoring of leading companies in the dynamic healthcare and pharmacy sectors.